During the last session, Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s traded shares were 1.81 million, with the beta value of the company hitting 1.71. At the end of the trading day, the stock’s price was $9.27, reflecting an intraday gain of 5.22% or $0.46. The 52-week high for the ADPT share is $10.28, that puts it down -10.9 from that peak though still a striking 67.75% gain since the share price plummeted to a 52-week low of $2.99. The company’s market capitalization is $1.41B, and the average trade volume was 2.45 million shares over the past three months.
Adaptive Biotechnologies Corp (ADPT) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.25. ADPT has a Sell rating from 1 analyst(s) out of 11 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
Adaptive Biotechnologies Corp (ADPT) registered a 5.22% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.22% in intraday trading to $9.27, hitting a weekly high. The stock’s 5-day price performance is 25.95%, and it has moved by 20.94% in 30 days. Based on these gigs, the overall price performance for the year is 187.89%.
The consensus price target of analysts on Wall Street is $14, which implies an increase of 33.79% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $18 respectively. As a result, ADPT is trading at a discount of -94.17% off the target high and 46.06% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -1.51%. While earnings are projected to return 22.63% in 2025, the next five years will return 29.40% per annum.
ADPT Dividends
Adaptive Biotechnologies Corp is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 14.0 million shares, is of RUBRIC CAPITAL MANAGEMENT LP’s that is approximately 9.4971% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $50.68 million.
Also, the Mutual Funds coming in first place with the largest holdings of Adaptive Biotechnologies Corp (ADPT) shares are ARK ETF Trust-ARK Genomic Revolution ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Mar 31, 2025 indicates that ARK ETF Trust-ARK Genomic Revolution ETF owns about 7.62 shares. This amounts to just over 5.02 percent of the company’s overall shares, with a $70.63 million market value. The same data shows that the other fund manager holds slightly less at 4.2, or about 2.76% of the stock, which is worth about $38.92 million.
